Saliva test for psychedelic depression treatment
Part of Mental health clinical trials.
This trial tests whether a simple saliva test can measure oxytocin levels during a psychedelic treatment for hard-to-treat depression. The goal is to find a biological marker that helps predict how well the therapy works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You have major depression that hasn't gotten better with standard treatments.
- You are currently in regular talk therapy (psychotherapy).
- You agree to stop most psychiatric medications (some antidepressants may be okay without tapering).
- You cannot have psychosis, bipolar disorder, high suicide risk, severe heart/liver/brain problems, or be pregnant or nursing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational medication (CYB003) for people with major depression whose current antidepressant isn't working well enough. It looks at whether this treatment can help improve depression symptoms.
This trial tests if inhaling DMT can help treat moderate to severe major depression. You may qualify if your depression has lasted at least two weeks and you have not changed medications recently.
This study tests whether a combination of DMT (a psychedelic) and propofol (a sedative) can help treat depression. You will receive both medicines in a hospital setting, and the team will monitor your response.
This trial tests whether psilocybin can help people with major depression who are currently having a depressive episode. It aims to understand how the treatment works and if it is safe and effective.
This study tests whether a single dose of psilocybin (a psychedelic compound) can help treat depression by looking at brain changes on MRI. It is designed for people with moderate-to-severe depression who have not responded well to other treatments.
This study collects saliva samples to look for molecules linked to emotions. It may help researchers develop new ways to measure feelings using a simple saliva test.
Hear when a new Major Depressive Disorder (MDD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.